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Abstract
Background: The Mental Health Inventory (MHI-5) and the Mental Health Component Summary
score (MCS) derived from the Short Form 36 (SF-36) instrument are well validated and reliable
scales. A drawback of their construction is that neither has a clinically validated cutpoint to define
a case of common mental disorder (CMD). This paper aims to produce cutpoints for the MHI-5
and MCS by comparison with the General Health Questionnaire (GHQ-12).
Methods:  Data were analysed from wave 9 of the British Household Panel Survey (2000),
providing a sample size of 14,669 individuals. Receiver Operating Characteristic (ROC) curves
were used to compare the scales and define cutpoints for the MHI-5 and MCS, using the following
optimisation criteria: the Youden Index, the point closest to (0,1) on the ROC curve, minimising
the misclassification rate, the minimax method, and prevalence matching.
Results: For the MHI-5, the Youden Index and the (0,1) methods both gave a cutpoint of 76,
minimising the misclassification rate gave a cutpoint of 60 and the minimax method and prevalence
matching gave a cutpoint of 68. For the MCS, the Youden Index and the (0,1) methods gave
cutpoints of 51.7 and 52.1 respectively, minimising the error rate gave a cutpoint of 44.8 and both
the minimax method and prevalence matching gave a cutpoint of 48.9. The correlation between the
MHI-5 and the MCS was 0.88.
Conclusion: The Youden Index and (0,1) methods are most suitable for determining a cutpoint
for the MHI-5, since they are least dependent on population prevalence. The choice of method is
dependent on the intended application. The MHI-5 performs remarkably well against the longer
MCS.
Background
The common mental disorders of anxiety and depression
(CMD) are leading causes of morbidity and disability and
constitute a major public health burden [1]. The CMDs
are most commonly measured in population studies
using the General Health Questionnaire (GHQ-12) [2].
Another frequently used scale is the Mental Health Inven-
tory (MHI-5) [3] which is included in the Short Form 36
(SF-36). The MHI-5 is a well validated and reliable meas-
ure of mental health status [4], but an important limita-
tion of its use is that it was not developed with a validated
cutpoint to define a case of CMD. The SF-36 can also be
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used to construct the Mental Health Component Sum-
mary score (MCS) which is another measure of mental
health status that is widely used in population surveys but
has no clinically validated cutpoint [5]. In this paper we
aim to derive generalisable cutpoints for the MHI-5 and
MCS using the GHQ-12 as a gold standard, using five dif-
ferent optimisation criteria.
Methods
Dataset
Data from wave 9 of the British Household Panel Survey
(BHPS) [6] were used in this analysis. The BHPS is a lon-
gitudinal study carried out in England, Scotland and
Wales (in wave 9). The first wave of the BHPS was carried
out in 1991 with a nationally representative sample of
5,500 households. The BHPS follows households through
time, with an annual interview of every member of the
household aged 16 and over. Individuals interviewed in
the first sample who subsequently set up their own house-
hold continued to participate in the survey, as well as
every individual in the new household. All waves of the
BHPS include the GHQ-12, but wave 9 of the study
(2000) also included the SF-36 version 1. There is com-
plete information on both of these instruments for all
14,669 individuals in the dataset. Of those present at wave
8, 83.4% were successfully followed up at wave 9.
Mental Health Measures
The GHQ-12 comprises twelve questions, each with a set
of Likert scale responses which score the question as 0, 1,
2 or 3. There are two ways of scoring the GHQ-12. Either
the sum of these responses is used to provide a score rang-
ing between 0 and 36 or alternatively, the response to
each question is deemed positive if it is greater than one
and the number of positives provides the score. This
results in a score between 0 and 12 for each individual.
This latter method is used in this study. Different studies
use different cutpoints between 2 and 4 to define a case of
common mental disorder. In this paper we use the most
widely accepted convention of a score of three or more
defined as a case [7]. The SF-36 version 1 consists of eight
subscales measuring Physical Functioning, Role Physical,
Bodily Pain, General Health, Vitality, Social Functioning,
Role Emotional and Mental Health. The MHI-5 comprises
five questions. There are six possible responses to the
questions, scored between 1 and 6. The score for each
individual therefore ranges between 5 and 30. This is then
transformed into a variable ranging from 0–100 using a
standard linear transformation [5]. A different mental
health score, which incorporates all eight subscales of the
SF-36, called the Mental Health Component Summary
(MCS) can also be constructed. It was calculated in the
standard way [5], using UK norms [8] and factor loadings
[9].
On both the MHI-5 and the MCS high scores indicate
good mental health, unlike the GHQ-12. Both the MHI-5
and the GHQ-12 scales have discrete distributions. The
GHQ-12 takes on only 13 different values, while the MHI-
5 produces only 26 different values. The MCS is a contin-
uous variable, with 11,003 different values being calcu-
lated for the 14,669 individuals in the BHPS dataset.
Statistical Methods
Sensitivity and Specificity
In order to identify a cutpoint for any new measure, it
needs to be compared to another scale which can classify
people as a case or a non-case. Ideally, this scale would be
a gold standard and would produce no misclassifications.
In the field of mental health the acknowledged gold
standard is a standardised interview. A well validated
scale, such as the GHQ-12, with an associated cutpoint to
distinguish cases from non-cases is a good alternative. The
GHQ-12 classifies each individual in the dataset as a case
or a non-case. Our aim is to find the cutpoints on the
MHI-5 and MCS that imitate the GHQ-12 cutpoint as
closely as possible. Individuals with mental health scores
less than or equal to the cutpoint on the MHI-5 or MCS
will be defined as cases. The evaluation of a cutpoint
involves the twin concepts of sensitivity and specificity.
The sensitivity of a test is the probability of a case testing
positive (i.e. a true positive). The specificity of a test is the
probability of a non-case testing negative (i.e. a true nega-
tive). Clearly a good test has a large sensitivity, but a test
which automatically classifies everyone as a case has a sen-
sitivity of one (the maximum possible), even though it is
completely uninformative. There is a trade-off to be made,
then, between sensitivity and specificity. As the cutpoint is
decreased, the sensitivity decreases, while the specificity
increases.
Receiver Operating Characteristic Curves
For each possible cutpoint on the measure under investi-
gation there is an associated sensitivity and specificity.
These can be summarised using a receiver operating char-
acteristic (ROC) curve. A ROC curve plots the sensitivity
(i.e. true positive rate) on the y-axis against one minus the
specificity (i.e. false positive rate) on the x-axis. Each point
on the curve represents a different cutpoint on the new
measure. A diagonal line at 45 degrees, known as the line
of chance, would result from a test which allocated sub-
jects randomly.
Optimisation Criteria
There are several approaches to choosing a cutpoint on a
ROC curve. Five of these will be investigated in this study.
Each method focuses on optimising a different criterion
and so may produce a different cutpoint. The five meth-
ods are: 1. the Youden Index [10], 2. the point closest to
the upper left corner, coordinates (0,1), as used by Hol-BMC Psychiatry 2008, 8:10 http://www.biomedcentral.com/1471-244X/8/10
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mes [11] 3. the misclassification rate, 4: the minimax
method [12] and 5. prevalence matching, as used by
Hoeymans et al [13]. Only the first two have a graphical
interpretation on the ROC curve.
Youden Index
In general, a good cutpoint is one which produces both a
large sensitivity and a large specificity. An intuitive
method, therefore, is to maximise the sum of the sensitiv-
ity and specificity, S, i.e. satisfy equation 1
S = max(Sensitivity + Specificity) (1)
This approach assumes that sensitivity and specificity are
equally important. This is exactly equivalent to the
Youden index, shown in equation 2, since subtracting a
constant does not affect the optimal cutpoint. This can be
interpreted as choosing the point on the ROC curve with
the largest vertical distance from the line of chance.
J = max(Sensitivity + Specificity - 1) (2)
Shortest distance to upper left corner
The second optimisation method investigated in this
paper is to choose the cutpoint associated with the point
on the ROC curve closest to the upper left corner. This
entails finding the cutpoint which minimises d in equa-
tion 3. This method also places equal weight on the sensi-
tivity and specificity.
The rationale behind this is that a perfect ROC curve
would pass through the point (0,1) (i.e. Sensitivity = 1
&Specificity = 1 for some cutpoint). Selecting the point on
the curve which is closest to this point of perfection is one
way to choose a cutpoint. The Youden index and the (0,1)
criterion are illustrated in Figure 1.
Misclassification rate
Alternatively, the misclassification rate could be mini-
mised. For this we define the false positive rate (FPR) to be
FPR = (Non-case Prevalence)×(1-Specificity) (4)
and the false negative rate (FNR) to be
FNR = (Case Prevalence)×(1-Sensitivity) (5)
and it is the sum of these two terms that is minimised.
This essentially gives weights to the sensitivity and specif-
icity based on the prevalence of cases. If the population
has a very low prevalence of cases, then more weight
would be given to specificity. If the prevalence is high,
then sensitivity takes precedence. This presupposes that
the penalty incurred for a false positive is equal to that
incurred for a false negative. If this does not hold, the sum
can be weighted according to the penalties incurred for
false positives and negatives, i.e. minimise
θ×(1-Sensitivity) + (1 - θ)×(1-Specificity) (6)
where θ is the weight attached to the sensitivity. Choosing
this weight may not be straightforward. For instance, in
this study it is difficult to compare the consequences of
both types of misclassification. Expression 6 is equivalent
to equations 1 and 2 with θ set to 0.5, and equivalent to
prevalence matching (described below) with θ set to the
population prevalence.
Minimax Criterion
The minimax criterion involves minimising the frequency
of the most common error. In a two by two classification
table, this is equivalent to minimising the maximum of
the off-diagonal elements.
This involves minimising M in equation 7.
M = max(FPR, FNR) (7)
This is similar to minimising the misclassification rate,
except instead of the sum of FPR and FNR being mini-
mised, the maximum of the two terms is minimised.
Prevalence Matching
The final optimisation criterion we consider is to choose a
cutpoint which results in the proportion of the screened
d Sensitivity Specificity =− + − () () 11
22 (3)
Graphical illustration of the Youden Index (J) and the (0,1)  criterion Figure 1
Graphical illustration of the Youden Index (J) and the 
(0,1) criterion. 1. (0,1) refers to the minimum distance 
between the point (0,1) and the ROC curve. 2. J refers to the 
Youden Index in equation 2.
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population classified as positives (or cases) being closest
to the gold standard case prevalence. Those classed as pos-
itives comprise both true and false positives and so expres-
sion 8 is minimised, where the True Positive Rate (TPR) is
the sensitivity multiplied by the case prevalence.
|TPR + FPR - P(Case)| (8)
It can be shown that in the continuous case (i.e. where the
new measure is capable of infinite subdivision) this
method is equivalent to the minimax method. In discrete
cases, they will produce very similar results. It is important
to clarify at this point, that unlike other studies which
employ ROC curves, the area under the curve is not a
meaningful criterion to use here. The area under the curve
summarises the performance of an entire measure across
all cutpoints. It is appropriate when two new measures are
being compared against a gold standard in order to deter-
mine which of the new measures performs most similarly
to the gold standard. It cannot, however, be used to deter-
mine an optimum cutpoint on a scale.
Since the method uses the same dataset both to define cut-
points and assess the performance of those cutpoints,
there is the possibility of overestimating the sensitivity
and specificity. This potential source of bias is investigated
by repeating the analysis using 75% of the dataset (ran-
domly selected), and then assessing the performance of
the cutpoints produced on the remaining 25% of the data-
set.
Results
MHI-5 Results
First consider the MHI-5. Maximising the Youden index
leads to a cutpoint of 76 (a case of common mental disor-
der is defined by a score of less than or equal to 76) for the
MHI-5. Using the shortest distance from (0,1) criterion
the optimal cutpoint is also 76. In general, these two opti-
misation methods will not always give the same cutpoint
though the discrete nature of both scales means that in
practice they often will. Using the sample prevalence of
25.3% (according to the GHQ-12) to weight the sum of
the sensitivity and specificity (thereby minimising the
error rate) the corresponding cutpoint is 60. Using the
prevalence matching method of choosing a cutpoint the
optimal cutpoint is 68. This produces a case prevalence of
24.4%, which is the closest to the GHQ-12 case preva-
lence of 25.3%. The minimax method yields the same cut-
point as prevalence matching. The correlation between
the GHQ-12 and the MHI-5 is high (-0.65). Figure 2
shows the points on the ROC curve corresponding to each
of the cutpoints produced by the different optimisation
criteria.
MCS Results
Next, we examine the MCS. The Youden index and the
(0,1) methods produce very similar cutpoints of 51.7 and
52.1, respectively. Minimising the error rate produces a
cutpoint of 44.8 while both prevalence matching and the
minimax method indicate a cutpoint of 48.9. Table 1
summarises the results and illustrates the trade off that
must be made between sensitivity and specificity. Figure 3
shows the points on the ROC curve corresponding to each
of the cutpoints produced by the different optimisation
criteria. The correlation between the MCS and GHQ-12 is
the same as for the MHI-5 at -0.65.
Assessment of bias
Using three-quarters of the data to derive cutpoints
resulted in no change of optimum cutpoints for the MHI-
5. When these were applied to the unused 25% of the data
in order to assess their performance no systematic bias
was observed, with the sensitivity and specificity for each
cutpoint being equally likely to increase as decrease. The
situation was similar for the MCS, with most of the opti-
misation criteria producing identical cutpoints to those
produced by the full dataset (the only method which pro-
duced a slightly different cutpoint was the minimising the
misclassification method, which went from 44.8 to 45.1).
Again, when these cutpoints were applied to the unused
25% of the data, they produced sensitivities and specifici-
ties very close to those reported for the full dataset.
MHI-5 ROC curve using a GHQ caseness criterion of 3 or  more Figure 2
MHI-5 ROC curve using a GHQ caseness criterion of 
3 or more. 1. ROC curve based on a GHQ-12 caseness cri-
terion of 3 or more. Vertical lines indicate the optimum cut-
points using the five different optimisation criteria.
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Comparison of the MHI-5 and the MCS
It is also worth noting that the shorter MHI-5 performs
remarkably similar to the longer MCS, with the correla-
tion between the two being 0.88. Table 1 shows that the
error rates produced by the five optimisation methods are
very similar, for the two scales. Table 1 shows that the
MCS is only marginally more efficient at discriminating
cases of CMD than is the MHI-5, despite employing over
seven times as many questions. Figure 4 illustrates how
the cutpoints on the MHI-5 and the MCS vary with GHQ-
12 case prevalence (the GHQ-12 case prevalence was var-
ied by changing the cutpoint on the GHQ-12).
Table 1: MHI-5 and MCS cutpoints and associated test characteristics for five optimisation criteria
Scale Optimisation Criterion Cutpoint Sensitivity Specificity Positivity1 Rate Error Rate2 %
MHI-5 Youden Index 76 0.756 0.771 0.362 23.3
(0,1)3 76 0.756 0.771 0.362 23.3
Misclassification Rate 60 0.473 0.943 0.163 17.6
Minimax method 68 0.615 0.882 0.244 18.5
Prevalence Matching 68 0.615 0.882 0.244 18.5
MCS Youden Index 51.7 0.745 0.787 0.348 22.4
(0,1) 52.1 0.759 0.772 0.362 23.1
Misclassification Rate 44.8 0.476 0.941 0.164 17.6
Minimax method 48.9 0.630 0.874 0.253 18.8
Prevalence Matching 48.9 0.630 0.874 0.253 18.8
1Positivity rate refers to the proportion of the sample defined to be a case using each cutpoint.
2Error rate refers to the proportion of the sample classified differently to the GHQ-12. This comprises both false negatives and false positives.
3(0,1) refers to the criterion which minimises the distance between the point (0,1) and the ROC curve
MCS ROC curve using a GHQ caseness criterion of 3 or more Figure 3
MCS ROC curve using a GHQ caseness criterion of 3 or more. 1. ROC curve based on a GHQ-12 caseness criterion 
of 3 or more. Vertical lines indicate the optimum cutpoints using the five different optimisation criteria.
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Discussion
Main Findings
For the MHI-5 the five methods produce three distinct cut-
points. Both graphical approaches (the Youden Index and
the point closest to the upper left corner) produce a cut-
point of 76. Prevalence matching and the minimax
method both indicate that 68 is the optimal cutpoint,
while minimising the misclassification rate provides an
optimal cutpoint of 60. The five methods produced simi-
lar results for the MCS with the two graphical approaches
producing cutpoints of 51.7 and 52.1. Both prevalence
matching and the minimax method gave an MCS cutpoint
of 48.9 and minimising the missclassification rate pro-
duced an MCS cutpoint of 44.8. It is important to point
out that the reason the prevalence matching, minimax,
and minimising the misclassification methods give lower
cutpoints than the Youden or (0,1) criteria is due to the
fact that the case prevalence is less than 50% (25.3%). If
the case prevalence were greater than 50% this situation
would be reversed and the three aforementioned methods
would give cutpoints greater than the Youden or (0,1) cri-
teria.
The relationship between the optimum cutpoint and the
population case prevalence for the five optimisation
methods and for both the MHI-5 and the MCS was inves-
tigated in Figure 4 (the minimax method was excluded
since it was largely coincidental with prevalence match-
ing). For the minimising the error rate and prevalence
matching methods the optimal cutpoint varies greatly
with population prevalence, while the Youden index and
(0,1) methods are relatively independent of population
prevalence. This is the case for both scales. This invariance
under different population prevalences is a property that
is extremely useful for studies that span large and hetero-
geneous areas, such as international comparisons. Both
methods also have intuitive interpretations as described
earlier, and so there is very little to choose between them.
When the misclassification rate was minimised there was
still a error rate of 17.6% for both the MHI-5 and MCS,
which may imply that they measure slightly different con-
structs to the GHQ-12. This finding is echoed by Hoey-
mans et al [13] who noted that the MHI-5 was
uncorrelated with age, whereas older age groups scored
higher on the GHQ-12 (indicating worse mental health).
Relationship between prevalence and MHI-5 and MCS cutpoints for four optimisation methods Figure 4
Relationship between prevalence and MHI-5 and MCS cutpoints for four optimisation methods. 1. Case preva-
lence is altered by varying the cutpoint used to define caseness on the GHQ-12 from 1 to 12. 2. Solid line denotes the Youden 
Index. 3. Dashed line denotes the (0,1) method. 4. Dotted line denotes the minimising the error rate method. 5. Dashed and 
dotted line denotes the prevalence matching method. 6. The minimax method is excluded since it is predominantly coincidental 
with the prevalence matching method.
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Weinstein et al [14] drew attention to the fact that the
comparative nature of the GHQ-12 response choices is
not conducive to detecting chronic disorders. A subject
suffering from chronic anxiety disorder may well answer
the question "Have you recently lost much sleep over
worry?" with the response choice "no more than usual", if
their condition is a long-standing one. The MHI-5 and
MCS avoid this problem by employing less comparative
response choices. Another explanation for the lack of
complete agreement between the GHQ-12 and the two
SF-36 mental health measures is that they were designed
differently. The MHI-5 includes one or more questions on
each of the following mental health dimensions: anxiety,
depression, loss of behavioural/emotional control and
psychological well-being [3], while the MCS is a weighted
sum of all eight health dimensions of the SF-36. The
GHQ-12 on the other hand includes items on depression,
anxiety, social performance and somatic complaints [2].
However, the high correlations between the GHQ-12 and
both the MHI-5 and the MCS indicate that, despite these
differences, the three scales perform very similarly. This
can be seen in Table 1 where the five optimisation meth-
ods produce cutpoints on both scales with very similar
properties in terms of sensitivity, specificity, positivity rate
and error rate. As mentioned previously the correlation
between the MHI-5 and the MCS is high at 0.88.
More generally, this study has found that the minimax
method and prevalence matching methods give very sim-
ilar results. Indeed, in this study they produce identical
cutpoints. This is not a coincidence, as the two criteria
become equivalent if the scale in question is continuous
(and the probability of caseness is calculated from the
same dataset).
Investigators should give careful consideration to which
of these cutpoints is most appropriate for their study,
since selecting which criterion should be optimised
depends primarily on the intended application of the
resulting cutpoint. For instance, a study whose primary
goal is to identify cases in a given locality might do well to
minimise the misclassification rate. However, a study
interested in comparing CMD internationally should con-
sider utilising the Youden Index or the (0,1) method, as
these methods are most appropriate when the study area
encompasses regions with different case prevalences.
Prevalence matching has the advantage of simplicity but
will inevitably lead to different cutpoints in different pop-
ulations. The minimax method approximates to preva-
lence matching when the scale in question is continuous.
Comparison with Previous Studies
One study of 7,359 adults representative of the Dutch
general population used the GHQ-12 to derive a MHI-5
cutpoint using the prevalence matching method [13].
They used a less severe CMD case criterion of two or more
on the GHQ-12, giving a case prevalence of 22.8%. The
MHI-5 cutpoint which matched this prevalence most
closely was 72, resulting in a case prevalence of 20.6%. To
illustrate how this approach can lead to different results in
different populations, we carried out the equivalent pro-
cedure in the BHPS dataset. Using a GHQ-12 caseness cri-
terion of two or more classifies 32.9% of the dataset as
cases. The MHI-5 cutpoint which best matches this preva-
lence is 76 (providing a case prevalence of 36.2%).
One small study compared four psychiatric case-finding
instruments in 69 patients presenting to general practice
in Wales and chose cutpoints which provided an unde-
fined "similar sensitivity and specificity values for each
instrument" [15]. The Revised Clinical Interview Schedule
was used to define a case of CMD. This study identified an
MHI-5 cutpoint quoted as 71/72.
A report published in Dutch compared the MHI-5 with
the GHQ-12 in order to ascertain a cutpoint [16]. They
sampled 7,065 independently living individuals aged 18
to 64 from the general population. A score of two or more
on the GHQ-12 was used to define caseness, which classi-
fied 24.4% of the population as a case. They used the
Youden Index and prevalence matching methods. The
Youden Index indicated an MHI-5 cutpoint of 72, leading
to a case prevalence of 22.8%. The Composite Interna-
tional Diagnostic Interview (CIDI) was used to determine
whether individuals suffered from any of the following
disorders: depression, bipolar disorder, dysthymia, panic
disorder, agoraphobia, specific phobia, social phobia,
generalised anxiety disorder, obsessive compulsive disor-
der, schizophrenia, anorexia and bulimia. The percentage
of the population diagnosed with at least one of these dis-
orders was found to be 12.2%. The MHI-5 cutpoint which
matched this prevalence most closely was 60, producing a
case prevalence of 11.2%.
Three other studies have defined a cutpoint by comparing
MHI-5 scores with a range of different validated clinical
interview schedules. These are summarised in turn below.
The wide range of cutpoints found reflects the wide variety
in sample sizes, study settings and outcomes of interest.
A study of 95 non-psychiatric patients who were HIV sero-
positive used the Structured Clinical Interview for DSM-
III-R (SCID-NP-HIV) psychiatric disorders [11] and found
a cutpoint of 52 using the (0,1) method. This study was
investigating more severe disorders than the CMD and so
produced a very low cutpoint. Applying this cutpoint to
the BHPS dataset would identify only 8.3% of the individ-
uals as cases. A study of 4,036 German nationals resident
in an area of approximately 50 km in diameter surround-
ing Lubeck used the Munich Composite InternationalBMC Psychiatry 2008, 8:10 http://www.biomedcentral.com/1471-244X/8/10
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Diagnostic Interview (M-CIDI) and found a cutpoint of
65 [17]. This study used the (0,1) method. This low cut-
point can be attributed to the fact that the M-CIDI is used
to diagnose DSM-IV Axis 1 psychiatric disorders which are
more extreme conditions than the common mental disor-
ders.
Another study investigated the validity of the MHI-5 for
assessing major depression using 1,444 functionally
impaired, community dwelling elderly Americans. The
gold standard against which the MHI-5 was compared was
the MINI-International Neuro-Psychiatric Interview
Major Depressive Episode (MINI-MDE) module. The
Youden index optimisation criterion produced a cutpoint
quoted as 59/60. Again, the study focussed on major
depression and so produced a lower cutpoint than the cut-
point of 80 indicated by our paper.
A Norwegian study used the MHI-5 as the gold standard
to define cutpoints for a different measure [18]. Postal
questionnaire surveys with MHI-5 information were
returned by 6865 (70.5% response rate) individuals and
cutpoints of 52 and 56 were used successively.
To our knowledge no study has attempted to identify a
cutpoint of the MCS.
Strengths and Limitations of the Study
This study compares two measures derived from a ques-
tionnaire that is frequently employed in population
research [18], using a large, representative sample of the
UK population and five different optimisation criteria.
The main strength of our study is that the sample size used
is nearly twice that of the next largest study. So, while it is
well known that optimal cutpoints vary as a function of
the population being investigated, severity of caseness,
case prevalence and gold standard employed, this study
compares the cutpoints derived from five optimisation
criteria, for the MHI-5 and the MCS. This facilitates an
objective and comprehensive assessment of the best cut-
point for use in different studies.
A criticism of the approach adopted in this paper regards
the use of the GHQ-12 as the comparative gold standard.
In ROC curve analysis, a measure is supposed to be com-
pared to a gold standard which can categorise the sample
without error. In the field of mental health a standardised
interview schedule is considered the gold standard and
would be preferable to using the GHQ-12. A scale such as
the GHQ-12 is likely to have lower sensitivity and specifi-
city than a standardised interview schedule and this may
affect the resulting cutpoints. Unfortunately, the BHPS
did not administer a standardised interview schedule. A
disadvantage to using a standardised interview schedule is
that it is resource intensive, limiting the sample size
achievable. Administering the GHQ-12 is, by comparison,
inexpensive and efficient. Also, it can be argued that the
GHQ-12 is a well validated and reliable scale, with vali-
dated cutpoints, and as such is a reasonable instrument
against which to measure other scales.
A further potential criticism concerns the crude nature of
cutpoints resulting in the loss of information in the varia-
ble being dichotomised. One method which seeks to
avoid this problem is to use stratum-specific likelihood
ratios (SSLRs) [19], defined as the ratio of the probability
of a given test result when the disease is present and the
probability of the same test result when the disease is
absent. Instead of plotting these against one another as in
a ROC curve, the SSLR approach examines the ratio of the
two. These SSLRs can be calculated for each possible score
on the scale in question. Nomograms can then be con-
structed providing the probability that a given individual
is a case depending on their score. While this approach
certainly retains more information than a simple cutpoint
and may be intuitively appealing, it does not avoid the
problem of having to choose a cutpoint in many situa-
tions since the SSLRs may still need to be summarised for
practical purposes. Furthermore, the SSLR is more useful
for diagnostic purposes, while both the GHQ-12 and the
MHI-5 are intended as screening tools as opposed to diag-
nostic tools. The use of depression/anxiety or case finding
instruments has limited impact on the recognition, man-
agement or outcome of depression/anxiety in primary
care [20,21]. As such, a cutpoint on either scale is only
appropriate for use in research on populations and would
not be suitable for diagnostic purposes.
In the year that wave 9 of the BHPS was carried out
(2000), an updated version of the SF-36 was released [5].
The MHI-5 used in the SF-36 version two excludes the
response choice "a good bit of the time" as validation
studies found that this choice was not consistently
ordered in relation to the other categories [22]. However,
it has been shown that there is little difference in the per-
formance of the six and five choice response scale [5,17].
Conclusion
Of the five optimisation methods used in this study, the
Youden Index and the (0,1) method are the most suitable
for the determination of a generalisable cutpoint, since
they are least dependent on the population case preva-
lence. Both approaches indicate that the best cutpoint to
define a case of CMD using the MHI-5 is 76, while for the
MCS the Youden Index indicates a cutpoint of 51.7 and
the (0,1) method a cutpoint of 52.1. The MHI-5 has the
advantage over the GHQ-12 of brevity, consisting of only
five multiple choice questions and performs very similarly
to the longer MCS. Further validation studies, ideally
using a standardised interview schedule and a large popu-Publish with BioMed Central    and   every 
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lation, spanning different countries, are required to con-
firm our findings.
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